Generic medicine'

Generic medicines must meet the same standards of quality, safety, and efficacy as brand-name drugs. Regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), thoroughly evaluate generic drugs before granting approval for their sale and distribution. These agencies assess the manufacturing processes, active ingredients, and overall quality control of generic medicines to ensure they are equivalent to their brand-name counterparts.
Generic medicines are required to undergo bioequivalence studies, which compare their absorption, distribution, metabolism, and elimination in the body to that of the brand-name drug. These studies ensure that generic medicines deliver the same amount of active ingredient into the bloodstream within an acceptable range. Bioequivalence studies are essential in demonstrating that generic drugs perform in the same way as the original medication.
Generic medicines are manufactured using Good Manufacturing Practices (GMP), which are quality assurance guidelines enforced by regulatory authorities. GMP ensures that generic drug manufacturers maintain consistent production processes, adequate quality control measures, and reliable supply chains. Compliance with GMP standards helps to ensure the quality and reliability of generic medicines.
For further information
please contact: info@sterispharma.com
Call : 8209542042
Visit : sterisonline.com